Additionally, DDR mechanisms are not only essential for responses to chemotherapy, but also regulate the programmed death-ligand (PD-L1) expression on tumor cells or immune cells by activating cell cycle checkpoints, producing neo-antigen epitopes, and other mechanisms which may be a potential therapeutic target for immunotherapy. The gene discussed is CD274; the disease is neoplasm.